Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Sophia von Stockum, Kerstin Becker, Anja Bauerfeind, Christian Franke, Franca Fruzzetti, Joaquim Calaf, Christoph Keck & Klaas Heinemann. (2023) NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study. Gynecological Endocrinology 39:1.
Read now
Read now
Lara Tiranini, Laura Cucinella, Silvia Martella, David Bosoni, Ellis Martini & Rossella E. Nappi. (2023) Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?. Expert Review of Neurotherapeutics 23:4, pages 377-388.
Read now
Read now
Kristina Gemzell-Danielsson, Angelo Cagnacci, Nathalie Chabbert-Buffet, Jonathan Douxfils, Jean-Michel Foidart, Ali Kubba, Luis Ignacio Lete Lasa, Diana Mansour, Joseph Neulen, Jaoquim Neves, Fátima Palma, Thomas Römer, Robert Spaczyński & Vera Tóth. (2022) A novel estetrol-containing combined oral contraceptive: European expert panel review. The European Journal of Contraception & Reproductive Health Care 27:5, pages 373-383.
Read now
Read now
Elizabeth A. Micks & Jeffrey T. Jensen. (2020) A technology evaluation of Annovera: a segesterone acetate and ethinyl estradiol vaginal ring used to prevent pregnancy for up to one year. Expert Opinion on Drug Delivery 17:6, pages 743-752.
Read now
Read now
Jeffrey T. Jensen, Johannes Bitzer, Rossella E. Nappi, Christiane Ahlers, Ralf Bannemerschult & Susanne Parke. (2020) Pooled analysis of bleeding profile, efficacy and safety of oral oestradiol valerate/dienogest in women aged 25 and under. The European Journal of Contraception & Reproductive Health Care 25:2, pages 98-105.
Read now
Read now
J. Bitzer. (2019) Overview of perimenopausal contraception. Climacteric 22:1, pages 44-50.
Read now
Read now
Franca Fruzzetti, Daria Perini, Lara Fornaciari, Marinella Russo, Fiorella Bucci & Angiolo Gadducci. (2016) Discontinuation of modern hormonal contraceptives: an Italian survey. The European Journal of Contraception & Reproductive Health Care 21:6, pages 449-454.
Read now
Read now
Anita L Nelson. (2015) An update on new orally administered contraceptives for women. Expert Opinion on Pharmacotherapy 16:18, pages 2759-2772.
Read now
Read now
Kai J. Buhling, Lisa Klovekorn, Benita Daniels, Friederike S. G. Studnitz, Christine Eulenburg & Alfred O. Mueck. (2014) Contraceptive counselling and self-prescription of contraceptives of German gynaecologists: Results of a nationwide survey. The European Journal of Contraception & Reproductive Health Care 19:6, pages 448-456.
Read now
Read now
Nicolas Mendoza, Tommaso Simoncini & Alessandro D. Genazzani. (2014) Hormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies. Gynecological Endocrinology 30:12, pages 850-860.
Read now
Read now
Edith Weisberg. (2014) Developments in contraception. Expert Opinion on Pharmacotherapy 15:2, pages 203-210.
Read now
Read now
Anita L Nelson. (2012) New developments in oral contraception: clinical utility of estradiol valerate/dienogest (Natazia®) for contraception and for treatment of heavy menstrual bleeding: patient considerations. Open Access Journal of Contraception 3, pages 49-63.
Read now
Read now
Articles from other publishers (25)
Ana Teresa Timóteo, Regina Ribeiras, Rita Calé, Brenda Moura, Ana G. Almeida, Cristina Gavina, Sofia Cabral, Natália António, Fátima Franco, Rita Ilhão Moreira, Fernanda Geraldes, Ana Paula Machado, Fátima Palma, Vera Pires da Silva & Lino Gonçalves. (2023) Saúde cardiovascular da mulher – Documento de Consenso da Sociedade Portuguesa de Cardiologia, Sociedade Portuguesa de Ginecologia, Sociedade Portuguesa de Obstetrícia e Medicina Materno‐Fetal, Sociedade Portuguesa de Contraceção e Associação Portuguesa de Medicina Geral e Familiar. Revista Portuguesa de Cardiologia 42:12, pages 1001-1015.
Crossref
Crossref
Andrew M. Kaunitz, Sharon L. Achilles, János Zatik, Steven Weyers, Terhi Piltonen, Larisa Suturina, Inna Apolikhina, Celine Bouchard, Melissa J. Chen, Jeffrey T. Jensen, Carolyn L. Westhoff, Maud Jost, Jean Michel Foidart & Mitchell D. Creinin. (2022) Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women. Contraception 116, pages 29-36.
Crossref
Crossref
K Gemzell‐Danielsson, D Apter, J Zatik, S Weyers, T Piltonen, L Suturina, I Apolikhina, M Jost, MD Creinin & J‐M Foidart. (2021) Estetrol‐Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia. BJOG: An International Journal of Obstetrics & Gynaecology 129:1, pages 63-71.
Crossref
Crossref
Laure Morimont, Hélène Haguet, Jean-Michel Dogné, Ulysse Gaspard & Jonathan Douxfils. (2021) Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk. Frontiers in Endocrinology 12.
Crossref
Crossref
Clare Barnett, Anja Bauerfeind, Sophia von Stockum & Klaas Heinemann. (2021) Thromboembolic safety profile of low-dose estradiol (valerate) in combined hormonal preparations: Implications for the development of new hormonal endometriosis and uterine fibroid therapies. Journal of Endometriosis and Pelvic Pain Disorders 13:3, pages 195-204.
Crossref
Crossref
Christine Klipping, Ingrid Duijkers, Marie Mawet, Catherine Maillard, Adriana Bastidas, Maud Jost & Jean-Michel Foidart. (2021) Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone. Contraception 103:4, pages 213-221.
Crossref
Crossref
Natalia V. Aganezova & Sergey S. Aganezov. (2021) Real clinical practice and contraception for young women with children. Gynecology 23:1, pages 25-32.
Crossref
Crossref
LUDMILLA C. DO ESPÍRITO SANTO NERY, LESLIE C.S. BRAZ, LETICIA L.D.M. FERREIRA, FLÁVIA P. VIEIRA, LEANDRO L. DA SILVA, HELENE N.H. BLANC & JULIANA M. RAIMUNDO. (2021) A combined injectable contraceptive improves plasma redox status and does not induce vascular changes in female rats. Anais da Academia Brasileira de Ciências 93:3.
Crossref
Crossref
A. Cattoni, F. Parissone, I. Porcari, S. Molinari, N. Masera, M. Franchi, S. Cesaro, R. Gaudino, P. Passoni & A. Balduzzi. (2021) Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: Practical recommendations. Blood Reviews 45, pages 100730.
Crossref
Crossref
Martin Birkhaeuser. 2021. Female and Male Contraception. Female and Male Contraception
361
397
.
Mariagrazia StracquadanioMariagrazia Stracquadanio. 2020. Managing Women’s Hyperandrogenism. Managing Women’s Hyperandrogenism
35
83
.
Rosângela C. Rodrigues, Flávia Schechtman Belham, Ana Garcia, Corina Satler, Carlos Tomaz & Maria Clotilde H. Tavares. (2019)
Continuous Use of Combined Hormonal Contraceptive and the Effect on Blood Coagulation Factors in Female Capuchin Monkeys (
Sapajus libidinosus
)
. International Journal of Endocrinology 2019, pages 1-9.
Crossref
Crossref
Taniqua A. Miller, Rebecca H. Allen, Andrew M. KaunitzCarrie A. Cwiak. (2018) Contraception for midlife women: a review. Menopause 25:7, pages 817-827.
Crossref
Crossref
Cornelis Kluft, Yvette Zimmerman, Marie Mawet, Christine Klipping, Ingrid J.M. Duijkers, Jacoline Neuteboom, Jean-Michel Foidart & Herjan Coelingh Bennink. (2017) Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiol. Contraception 95:2, pages 140-147.
Crossref
Crossref
John Dimkpa Ojule & Emmanuel Okwudili Oranu. (2017) Combined Oral Contraceptive Use at the University of Port Harcourt Teaching Hospital, Port Harcourt, Southern Nigeria: A-20 Year Review. Journal of Biosciences and Medicines 05:06, pages 7-17.
Crossref
Crossref
G. B. Dikke. (2017) Failure from the previously selected method of contraception and strategy for improving commitment. Problemy reproduktsii 23:5, pages 54.
Crossref
Crossref
G. B. Dikke. (2016) How to reduce the number of side effects produced by COCs and improve adherence: simple tips for practitioners. Medical Council:2, pages 10-13.
Crossref
Crossref
Louis J Gooren, Katrien Wierckx & Erik J Giltay. (2014) Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern. European Journal of Endocrinology 170:6, pages 809-819.
Crossref
Crossref
He-Lin Lu, Zong-Wen Wu, Shu-Yong Song, Xiao-Dan Liao, Yan Zhu & Yun-Sheng Huang. (2014) An Improved Synthesis of Nomegestrol Acetate. Organic Process Research & Development 18:3, pages 431-436.
Crossref
Crossref
Lee P. Shulman. (2014) The Best Prophet of the Future is the Past: Oral Contraception and Novel Components. Journal of Women's Health 23:3, pages 195-196.
Crossref
Crossref
Marta Martín Millán & Santos Castañeda. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
615
634
.
Mark P. Thomas & Barry V.L. Potter. (2013) The structural biology of oestrogen metabolism. The Journal of Steroid Biochemistry and Molecular Biology 137, pages 27-49.
Crossref
Crossref
D. Foth, T. Römer & H.-J. Ahrendt. (2013) Hormonelle Kontrazeption mit östradiolhaltigen KombinationspräparatenHormonal contraception with estradiol-containing combined preparations. Gynäkologische Endokrinologie 11:3, pages 162-167.
Crossref
Crossref
David Crook. 2013. Contraception. Contraception
35
41
.
Lee P Shulman. (2013) Changing convention in combination oral contraceptives: estradiol and nomegestrol acetate in a monophasic 24/4 regimen. Journal of Family Planning and Reproductive Health Care 39:3, pages 211-216.
Crossref
Crossref